* Screening the prevalence of vitamin D deficiency among Egyptian hemodialysis patients on a single center (Ain Shams University hospital). * Assessing the effect of the native type of vitamin D (Cholecalciferol) on replenishing its deficiency via extra-renal vitamin D receptors (VDR), among Egyptian hemodialysis patients. * Assessing the effect of cholecalciferol on vascular calcification among Egyptian hemodialysis patients. * Assessing the effect of cholecalciferol on Blood pressure, parathyroid hormone.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
60
Native vitamin D dose of 200IU to be given once per month to hemodialysis patients
A Placebo ampule will be given to hemodialysis patients once per month with their standard treatment for 3 months period. Same color, odor and size, only without the active constituent.
Ain Shams University Hospital
Cairo, Egypt
Vitamin D level
Target serum Vitamin D level ≥ 30 ng/ml
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.